CompletedPHASE2, PHASE3NCT00624078
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Studying Scorpion envenomation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Principal Investigator
- Leslie Boyer, M.DVIPER Institute
- Intervention
- Antivenin Centruroides (scorpion) F(ab)2 Anascorp™(drug)
- Enrollment
- 1426 target
- Eligibility
- All sexes
- Timeline
- 2005 – 2010
Study locations (18)
- Casa Grande Regional Medical Center, Casa Grande, Arizona, United States
- Chandler Regional, Chandler, Arizona, United States
- Southeast Arizona Medical Center, Douglas, Arizona, United States
- Mercy Gilbert Medical Center, Gilbert, Arizona, United States
- Banner Thunderbird Medical Center, Glendale, Arizona, United States
- Banner Baywood Medical Center, Mesa, Arizona, United States
- Gila Health Resources, Morenci, Arizona, United States
- Holy Cross Hospital, Nogales, Arizona, United States
- Maricopa Medical Center, Phoenix, Arizona, United States
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- John C. Lincoln, Phoenix, Arizona, United States
- Mt. Graham Regional Medical Center, Safford, Arizona, United States
- San Carlos Indian Hospital, San Carlos, Arizona, United States
- Scottsdale Healthcare, Scottsdale, Arizona, United States
- Tucson Medical Center, Tucson, Arizona, United States
- +3 more locations on ClinicalTrials.gov
Collaborators
University of Arizona
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00624078 on ClinicalTrials.gov